Being able to robustly reconstruct 3D faces from 2D images is a topic of pivotal importance for a variety of computer vision branches, such as face analysis and face recognition, whose applications are steadily growing. Unlike 2D facial images, 3D facial data are less affected by lighting conditions and pose. Recent advances in the computer vision field have enabled the use of convolutional neural networks (CNNs) for the production of 3D facial reconstructions from 2D facial images. This paper proposes a novel CNN-based method which targets 3D facial reconstruction from two facial images, one in front and one from the side, as are often available to law enforcement agencies (LEAs). The proposed CNN was trained on both synthetic and real facial data. We show that the proposed network was able to predict 3D faces in the MICC Florence dataset with greater accuracy than the current state-of-the-art. Moreover, a scheme for using the proposed network in cases where only one facial image is available is also presented. This is achieved by introducing an additional network whose task is to generate a rotated version of the original image, which in conjunction with the original facial image, make up the image pair used for reconstruction via the previous method.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466432 | PMC |
http://dx.doi.org/10.3390/jimaging7090169 | DOI Listing |
Int J Oral Maxillofac Surg
January 2025
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China; National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing, China; National Clinical Research Center for Oral Diseases, Beijing, China. Electronic address:
The aim of this study was to evaluate the correlation between maxillary defects and facial asymmetry, and to establish categories for visual perception of facial asymmetry. The facial data of 47 patients who underwent maxillary resection due to tumors were captured using stereophotogrammetry. Facial asymmetry was measured using a landmark-independent method and assessed with a Likert scale.
View Article and Find Full Text PDFPediatrics
January 2025
Johns Hopkins University, Baltimore, Maryland.
Water beads are superabsorbent polymer balls. They were originally marketed for agricultural and decorative applications and are now sold as sensory toys. They can be harmful to children in 2 ways.
View Article and Find Full Text PDFClin Case Rep
February 2025
Personalized Precision Health Systems Foundation Bengaluru Karnataka India.
A 42-year-old female with left nasal blockage, facial numbness, upper palate pain, and headache was diagnosed with fungal ball sinusitis via CT scan. Refusing surgery, she opted for Ayurveda. Comprehensive treatment led to complete symptom resolution and a clear CT scan at 3 months.
View Article and Find Full Text PDFClin Cosmet Investig Dermatol
January 2025
Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.
Purpose: The aim was to quantitatively evaluate the effectiveness of LED light therapy combined with photoacceptor substances having anti-acne properties in reducing the symptoms of acne vulgaris.
Patients And Methods: 15 subjects aged 20 to 24 who suffered from moderate or severe acne lesions. The treatments were performed using a LED device (465-880 nm).
Front Immunol
January 2025
Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Prostate-Specific Membrane Antigen (PSMA) is a highly expressed and structurally unique target specific to prostate cancer (PCa). Diagnostic and therapeutic approaches in nuclear medicine, coupling PSMA ligands with radionuclides, have shown significant clinical success. PSMA-PET/CT effectively identifies tumors and metastatic lymph nodes for imaging purposes, while -PSMA-617 (Pluvicto) has received FDA approval for treating metastatic castration-resistant PCa (mCRPC).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!